Page results
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This page provides information about food and drink which may affect your ileostomy output.
-
Information about percutaneous endoscopic interlaminar lumbar discectomy for patients with sciatica.
-
Lumbar microdiscectomy is a spinal surgical procedure to remove part of a slipped (prolapsed) disc which is compressing a nerve root (the point at which the nerve leaves the spine).
-
Anterior cervical discectomy is an operation to relieve the pressure on your spinal cord or the nerves that supply your arms and hands (peripheral nerves). ‘Anterior’ means that the operation is through the front of your neck, usually on the right side.
File results
-
FOI/2022/0729 - Facilities for junior doctors
-
FOI/2022/0730 - Outpatient unit day procedures for haematology patients
-
FOI/2022/0748 - Services closed at Trust due to staffing issues
-
FOI/2022/0751 - Pharmacy solution to remotely monitor fridge temperature
-
FOI/2022/0754 - Respiratory devices
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0769 - Non-disclosure agreement to resolve sexual harassment cases
-
FOI/2022/0778 - Phone calls to 09020 44 24 11 from NHS Trust
-
FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer
-
FOI/2022/0789 - Agencies (including off framework) used to supply locum agency doctors